Recombinant Vector Vaccines Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Growth Prospects and Emerging Trends

Recombinant Vector Vaccines Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Press Release

Scientists need to perform intensive research and study to design a vaccine against particular microbes. This vaccine is based on the fundamental information such as how it infects the human or animal cell and what is the immune reaction of the infected cell. Researchers have developed different types of vaccines such as live attenuated vaccines, subunit vaccines, inactivated vaccines, conjugate vaccines, toxoid vaccines, DNA vaccines, and recombinant vector vaccines.

In recent years, the recombinant DNA technology has been used to generate new vaccines. This technology has helped scientists to develop recombinant vector vaccines against various bacterial and viral diseases. Recombinant vector vaccines are similar to DNA vaccines; however, these consist of an attenuated viral particle or bacterium as a vector.

Viruses adsorb on to a cell and inject their genetic material into them. Scientists have taken advantage of this viral nature and developed recombinant viral vector vaccines using attenuated virus as a carrier of the genetic material into the host cell. Recombinant vector vaccines have several advantages over other traditional vaccines. These vaccines closely mimic a natural infection caused by a particular microbe, thereby generating a good immune response against it. Recombinant vector vaccine strategy enables triggering of T- lymphocyte, and antigens, are thus presented to T- cell lymphocytes which generates a strong cell mediated immune response in the body against that particular antigen or microbe. Moreover, it reduces need of repeat dosage to treat a particular disease. Attenuated bacterium can also be used as an efficient vector to generate recombinant vector vaccines. In this case, genetic material is inserted into the bacterial vector, causing the bacteria to express the antigens of other microorganism onto its surface, generating an immune response. Strong research is being carried out to develop recombinant vector vaccines for rabies, HIV, and measles. Currently, adenovirus vectors, poxvirus vectors, and alphavirus vectors are extensively studied and used to prepare vaccines.

Browse more detail information about this report visit at at

Rapid development in molecular biology and genetic engineering is the key driver of the global recombinant vector vaccine market. The market is expected to show a rapid growth during the forecast period. However, substantial number of pharmaceutical challenges associated with the development of recombinant vector vaccines and stringent regulatory norms laid by the regulatory bodies is likely to restrain the market.

The global recombinant vector vaccines market can be segmented based on type of vector, disease type, and region. In terms of type of vector, the market can be bifurcated into recombinant viral vector vaccines and recombinant bacterial vector vaccines. The recombinant viral vector vaccines segment holds the maximum share of the market. Based on disease type, the market can be segmented into vector vaccines used to treat various viral and bacterial infections. Recombinant vector vaccines are being developed to treat cancer.

Geographically, the global recombinant vector vaccines market can be segmented into Europe, Asia Pacific, Latin America, North America, and Middle East & Africa. North America held a major share in 2016, owing to rise in technology advancements in molecular biology and genetic engineering. Increasing awareness, government initiatives, and availability of vector vaccines are expected to boost the growth of the market in Asia Pacific. The recombinant vector vaccines market in Europe is anticipated to grow during the forecast period owing to technological developments and increasing prevalence of infectious diseases.

Key players in the global recombinant vector vaccines market include Sanofi, Pfizer, Inc., Novartis AG, Neuron Biotech, Merck and Company, GlaxoSmithKline plc, CSL Limited, Biological E, and Bharat Biotech.

Request Brochure of this report visit at

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report at

Tags: , , , ,